Advertisement

Factors impacting on discordance with treatment plan in head and neck cancer patients: a retrospective, population-based cohort study

  • 112 Accesses

Abstract

Purpose

The aims of this study were to identify the factors and reasons impacting discordance with the treatment plan in head and neck cancer (HNC) patients and compare the differences between the concordance group and the discordance group.

Methods

This secondary analysis was conducted from population-based data from Taiwan collected from January 1, 2016, to June 30, 2018. Logistic regression analysis was used to identify the factors related to discordance with the treatment plan.

Results

We examined 1095 HNC patients, 12.1% of whom were discordant with treatment. Patients with advanced cancer stage, old age, and treatment plans of best supportive care (BSC) or surgery combined with radiation (RT), chemotherapy (CT), or chemoradiation (CCRT) were more likely to have discordance with their treatment plan. Of the 133 patients who were discordant with their treatment plan, the top reasons were as follows: “patients or their family considered patients’ poor physical condition (chronic disease or unstable systemic disease), difficulty in enduring any condition likely to cause physical discomfort from disease treatment,” “inconvenient transportation,” and “disease progression.”

Conclusions

Patients’ cancer stage, age, and types of treatment plans recommended significantly influenced discordance with treatment plan. Poor physical condition was the major reason for discordance with the treatment plan. Patients in the concordance group were significantly more likely than those in the discordance group to be younger than 65 years, have less advanced cancer stage, and be recommended to receive surgery rather than any other regimen. Multidisciplinary team care can help patients make positive decisions about treatment.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 199

This is the net price. Taxes to be calculated in checkout.

References

  1. 1.

    Weiss J, Hayes DN (2013) Classifying squamous cell carcinoma of the head and neck: prognosis, prediction and implications for therapy. Expert Rev Anticancer Ther 14:229–236. https://doi.org/10.1586/14737140.2014.863154

  2. 2.

    Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E836. https://doi.org/10.1002/ijc.29210

  3. 3.

    Taiwan Cancer Registry (2015) Annual report. Available from: http://crs.cph.ntu.edu.tw/. Accessed 21 Jan 2019

  4. 4.

    National Comprehensive Cancer Network (NCCN) (2018) NCCN guidelines for treatment of cancer by site—head and neck cancers treatment. Available from: https://www.nccn.org/professionals/physician_gls/default.aspx. Accessed 21 Feb 2019

  5. 5.

    Latter S, Maben J, Myall M, Young A (2007) Perceptions and practice of concordance in nurses’ prescribing consultations: findings from a national questionnaire survey and case studies of practice in England. Int J Nurs Stud 44:9–18

  6. 6.

    Horne R, Weinman J, Barber N et al (2005) Concordance, adherence and compliance in medicine taking. UK: National Coordinating Centre for NHS Service Delivery and Organization R and D. 1–309

  7. 7.

    Medicines Partnership (2003) Project evaluation toolkit. Medicines Partnership, London

  8. 8.

    Choi HG, Park B, Ahn SH (2017) Untreated head and neck cancer in Korea: a national cohort study. Eur Arch Otorhinolaryngol 274:1643–1650. https://doi.org/10.1007/s00405-016-4392-8

  9. 9.

    Huang HL, Kung PT, Chiu CF, Wang YH, Tsai WC (2014) Factors associated with lung cancer patients refusing treatment and their survival: a national cohort study under a universal health insurance in Taiwan. PLoS One 9(7):e101731. https://doi.org/10.1371/journal.pone.0101731 eCollection 2014

  10. 10.

    Liu CY, Chen WT, Kung PT et al (2014) Characteristics, survival, and related factors of newly diagnosed colorectal cancer patients refusing cancer treatments under a universal health insurance program. BMC Cancer 14:446. https://doi.org/10.1186/1471-2407-14-446

  11. 11.

    Suh WN, Kong KA, Han Y, Kim SJ, Lee SH, Ryu YJ, Lee JH, Shim SS, Kim Y, Chang JH (2017) Risk factors associated with treatment refusal in lung cancer. Thorac Cancer 8:443–450. https://doi.org/10.1111/1759-7714.12461

  12. 12.

    Mehta RS, Lenzner D, Argiris A (2012) Race and health disparities in patient refusal of surgery for early-stage non-small cell lung cancer: a SEER cohort study. Ann Surg Oncol 19:722–727. https://doi.org/10.1245/s10434-011-2087-3

  13. 13.

    Crespo-Lessmann A, Plaza V, González-Barcala FJ, Fernández-Sánchez T, Sastre J (2017) Concordance of opinions between patients and physicians and their relationship with symptomatic control and future risk in patients with moderate-severe asthma. BMJ Open Respir Res 4:e000189. https://doi.org/10.1136/bmjresp-2017-000189 eCollection 2017

  14. 14.

    Zhang K, Day C, Iorio ML (2017) Concordance of patient and physician perceptions of care in an orthopedic clinic. Orthopedics 40:242–246. https://doi.org/10.3928/01477447-20170418-05

  15. 15.

    Liao CT, Kang CJ, Lee LY, Hsueh C, Lin CY, Fan KH, Wang HM, Ng SH, Lin CH, Tsao CK, Fang TJ, Huang SF, Chang KP, Chang YL, Yang LY, Yen TC (2016) Association between multidisciplinary team care approach and survival rates in patients with oral cavity squamous cell carcinoma. Head Neck 38:E1544–E1553. https://doi.org/10.1002/hed.24276

  16. 16.

    Taplin SH, Weaver S, Salas E, Chollette V, Edwards HM, Bruinooge SS, Kosty MP (2015) Reviewing cancer care team effectiveness. J Oncol Pract 11:239–246. https://doi.org/10.1200/JOP.2014.003350

  17. 17.

    Badran KW, Heineman TE, Kuan EC, St John MA (2018) Is multidisciplinary team care for head and neck cancer worth it? Laryngoscope 128:1257–1258. https://doi.org/10.1002/lary.26919

  18. 18.

    Ivanics T, Proctor E, Chen Y, Ali H, Severson D, Nasser H, Colbert S, Susick L, Walker E, Petersen L, Bensenhaver J, Loutfi R, Nathanson SD, Newman LA (2019) Evaluation of a multidisciplinary team approach for generating survivorship care plan treatment summaries in patients with breast cancer [Epub ahead of print April 4, 2019]. J Oncol Pract 15:e467–e474. https://doi.org/10.1200/JOP.18.00509

  19. 19.

    World Health Organization (WHO) (2010) National Comprehensive Cancer Network (NCCN) (2018) NCCN guidelines for treatment of cancer by site—head and neck cancers treatment. Available from: https://www.nccn.org/professionals/physician_gls/default.aspx. Available from: https://icd.who.int/browse10/2010/en. Accessed 21 Feb 2019

  20. 20.

    World Health Organization (WHO) (2003) Adherence to long-term therapies: evidence for action. Available from: http://www.who.int/chp/knowledge/publications/adherence_report/en/index.html. Accessed 1 May 2019

  21. 21.

    Haynes RB, Yoa X, Degani A et al (2005) Interventions to enhance medication adherence. Cochrane Database Syst Rev 11:CD000011. https://doi.org/10.1002/14651858.CD000011.pub4

  22. 22.

    Ozen N, Cinar FI, Askin D et al (2019) Nonadherence in hemodialysis patients and related factors: a multicenter study. J Nurs Res. https://doi.org/10.1097/jnr.0000000000000309

  23. 23.

    Koedoot CG, Oort FJ, de Haan RJ et al (2004) The content and amount of information given by medical oncologists when telling patients with advanced cancer what their treatment options are. Palliative chemotherapy and watchful-waiting. Eur J Cancer 40:225e235

  24. 24.

    Jassem J, Ramlau R, Santoro A, Schuette W, Chemaissani A, Hong S, Blatter J, Adachi S, Hanauske A, Manegold C (2008) Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma. J Clin Oncol 26:1698–1704. https://doi.org/10.1200/JCO.2006.09.9887

  25. 25.

    Rosell L, Alexandersson N, Hagberg O, Nilbert M (2018) Benefits, barriers and opinions on multidisciplinary team meetings: a survey in Swedish cancer care. BMC Health Serv Res 18:249. https://doi.org/10.1186/s12913-018-2990-4

  26. 26.

    Tsay SL, Ko WS, Lin KP (2017) The lifestyle change experiences of cancer survivors. J Nurs Res 25:328–335. https://doi.org/10.1097/JNR.0000000000000178

  27. 27.

    Handschel J, Gellrich NC, Bremerich A, Krüskemper G (2013) Return to work and quality of life after therapy and rehabilitation in oral cancer. In Vivo 27:401–407

  28. 28.

    Lin HY, Chen SC, Peng HL, Chen MK (2015) Unmet information needs and clinical characteristics in patients with precancerous oral lesions. Eur J Cancer Care 24:911–919. https://doi.org/10.1111/ecc.12368

  29. 29.

    Agarwal J, Krishnatry R, Chaturvedi P, Ghosh-Laskar S, Gupta T, Budrukkar A, Murthy V, Deodhar J, Nair D, Nair S, Dikshit R, D’Cruz AK (2017) Survey of return to work of head and neck cancer survivors: a report from a tertiary cancer center in India. Head Neck 39:893–899. https://doi.org/10.1002/hed.24703

  30. 30.

    Giuliani M, Papadakos J, Broadhurst M, Jones J, McQuestion M, le LW, Beck L, Waldron J, Ringash J (2019) The prevalence and determinants of return to work in head and neck cancer survivors. Support Care Cancer 27:539–546. https://doi.org/10.1007/s00520-018-4343-6

  31. 31.

    Lin CR, Chen SC, Chang JT et al (2016) Fear of cancer recurrence and its impacts on quality of life in family caregivers of patients with head and neck cancers. J Nurs Res 24:240–248. https://doi.org/10.1097/jnr.0000000000000169

  32. 32.

    Health Promotion Administration, Ministry of Health and Welfare. (2019) 2007 Administrative Plan Bureau of Health Promotion, DOH, Executive Yuan. Available from http://www.hpa.gov.tw/Bhpnet/Web/HealthTopic/Topic.aspx?id=200712250034. Accessed 21 Feb 2019

  33. 33.

    Chiang TY, Wang CH, Lin YF, You JF, Chen JS, Chen SC (2018) Colorectal cancer in Taiwan: a case-control retrospective analysis of the impact of a case management programme on refusal and discontinuation of treatment. J Adv Nurs 74:395–406. https://doi.org/10.1111/jan.13443

  34. 34.

    Hsu YH, Chai HY, Lin YF, Wang CH, Chen SC (2017) Health-related quality of life and satisfaction with case management in cancer survivors. J Clin Nurs 26:4597–4604. https://doi.org/10.1111/jocn.13805

Download references

Acknowledgments

The authors thank MedCom for assistance with English editing.

Funding

This study was supported by a grant from Chang Gung Memorial Hospital (Grant/Award Number: CMRPG3J0241) Research Program in Taiwan.

Author information

Correspondence to Shu-Ching Chen.

Ethics declarations

The study was approved by the Institutional Review Board of Chang Gung Medical Foundation Institutional Review Board in Taiwan, and a permission certificate was obtained (Number: 201900232B0).

Conflict of interest

The authors declare that they have no competing interests.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Chang, Y., Lee, S., Liao, C. et al. Factors impacting on discordance with treatment plan in head and neck cancer patients: a retrospective, population-based cohort study. Support Care Cancer 28, 951–958 (2020). https://doi.org/10.1007/s00520-019-04904-z

Download citation

Keywords

  • Head and neck cancer
  • Treatment adherence and compliance
  • Therapeutic compliance
  • Patient noncompliance
  • Interdisciplinary health team
  • Medical care team